Malignant Muscle Neoplasm — Trials

Malignant Muscle Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

325 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 106
Recruiting: 58
Ph III recruiting: 6
Growth YoY: −35%
Industry share: 11%
Top sponsor: National Cancer Institute (NCI)
Termination share: 31.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (42)

clinicaltrialsPublishedShowing 51–78 of 78 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01653028	Alisertib in Treating Patients With Advanced or Metastatic Sarcoma	completed	Phase 2	72	National Cancer Institute (NCI)NIH	1	Nov 30, 2017	clinicaltrials
NCT00309907	Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant	completed	Phase 2	39	Children's Oncology GroupNETWORK	1	Sep 29, 2017	clinicaltrials